Dovev Apel

Partner

Adv. Dovev Apel is a partner at S. Horowitz & Co., with more than two decades of experience specializing in both intellectual property law (with a focus on patent, trademark, trade secret, and copyright litigation), and regulatory and product liability law applicable to life science product and services.

Dovev’s well-established practice is uniquely diversified, with a significant emphasis on regulatory and product liability matters in the life sciences sector, where Dovev is recognized as one of the leading lawyers in Israel.

Dovev supports major global and domestic companies in the pharmaceutical, biotechnology, medical device, food, digital health, and genetic testing sectors—as well as other technology-based companies—in navigating complex IP challenges and strategic regulatory and product liability and class actions matters.

Dovev combines deep technical expertise in life sciences with practical business acumen to deliver strategic solutions for clients ranging from startups to multinational corporations. Drawing on extensive experience in both contentious and non-contentious matters, Dovev has successfully appeared before all levels of Israeli courts and arbitration and administrative tribunals, and has gained distinctive expertise in handling complex administrative proceedings as well as claims and class actions involving life sciences-related products.

Dovev is great at getting disputes resolved efficiently... He is an excellent communicator, responding quickly and with clear instructions. A superb partner, in our goal of protecting and enforcing our valuable trademarks in Israel”

The Legal 500

Known for his hands-on approach, Dovev is described by his clients as an advisor that “Get straight to the core of the matter” and actively and continuously shapes the legal landscape through his contributions to Israeli legislation on IP and life-sciences regulatory matters. Clients value his unique expertise in product liability and class actions involving life sciences regulatory law, as well as his strategic guidance on pharmaceutical and medical device regulations.

Core Capabilities

  • Patent Litigation Strategy and Resolution
  •  Cross-Border IP Dispute Resolution
  • IP Portfolio Management and Protection
  • Life Sciences Regulatory Compliance
  • Class Action and product Liability Litigation
  • Healthcare Product Development and Commercialization
  • Medical Device Regulation
  • Pharmaceutical Industry Consultation
  • Legislative and Regulatory Policy Development

Notable Representations

  • Representation of Teva Pharmaceutical Industries Ltd., the world’s largest generic pharmaceutical company, in comprehensive patent litigation, oppositions, and trade secrets disputes as well as in all its regulatory and product liability matters.
  • Advising Nobel Biocare (Danaher Corporation) in complex patent ownership and trade secrets dispute for dental innovations
  • Representation of Smart Shooter Ltd. in patent oppositions and trade secrets litigation for revolutionary firearms technology
  • Advising JDE (Jacobs coffee) on strategic IP matters, including freedom to operate opinions
  • Representation of Lego in trademark prosecution and anti-counterfeiting proceedings
  • Representation of Sanofi in a complex class action filed with respect to  Imovane (Zopiclone, prescribed for insomnia) with respect to alleged insufficient warning in the product’s leaflet.
  • Representation of Taro Pharmaceutical Industries (a SUN Pharma subsidiary) in various regulatory and product liability claims, including precedent-setting proceedings in Israel related to its opioid product Percocet (Oxycodone and Paracetamol).
  • Representation of Dexcel Pharma in all its IP, regulatory and product liability matters, including class action filled following recalls of nitrosamine-containing products such as Valsartan and Ranitidine.
  • Advising multinational pharmaceutical companies including Shire, Takeda, and Novocure on regulatory compliance

recognition

Education

  • LL.B., cum laude, Hebrew University of Jerusalem, 2000

Admission

  • Israel Bar, 2001

News & Insights:

By Dovev Apel

Access our legal insights, thought leadership and expert analysis

Updates

Israel Enhances Reliance Policy – Medical Devices May Be Registered Based on Foreign Regulatory Authorities’ Approvals

The Israeli Ministry of Health has published a draft amendment to the Medical Device Regulations (Registration and Renewal of Medical Devices in the Registry and its Renewal), which formally and legislatively anchors the ongoing reform of the medical device registration

Updates

Update to Procedure No. 6 of the Ministry of Health – A Breakthrough in Pharmacovigilance Policy?

The Department of Risk Management and Medicinal Information at the Israeli Ministry of Health has published, for the public comments, a draft update to procedure No. 6, titled “Reporting of Adverse Events and New Safety Information”.

Position Application

Subscribe

Get the latest updates straight to your inbox

SHARE

Facebook
LinkedIn
WhatsApp
Email
Print